Discharge Planning Ends at the Funeral Home. That’s a Health System Failure.
By EVAN REID We reconcile medications at discharge because we decided, correctly, that the handoff…
By EVAN REID We reconcile medications at discharge because we decided, correctly, that the handoff out of a hospital is a clinical event with its own failure modes. Then a patient dies, and the same hospital that would not let them leave with an unreconciled med list hands the family a folder and a phone…
Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals. The post Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity appeared first on…
This analysis examines the share of Medicare Advantage enrollees who have a pre-existing condition that could result in a Medigap denial if they seek to switch to traditional Medicare outside their one-time 12-month trial period, including national estimates and estimates by age and by state. KFF finds that nearly three-quarters of Medicare Advantage enrollees (74%)…
This issue brief analyzes federal and state rules related to guaranteed issue requirements for Medigap policies and how they impact beneficiaries’ access to Medigap, including the implications for Medicare beneficiaries with pre-existing medical conditions and those under age 65 with long-term disabilities.
In 2027, combination of Diverge Health, Medical Home Network will partner with nearly 100 FQHCs and 300 independent practices
Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the doctor’s practice. The post Medicare Policy Shouldn’t Be Made in the Shadows appeared first on…
Corporate venture funds often chase financial returns while ignoring strategic value. Here’s what it takes to turn healthcare portfolio investments into lasting business impact. The post What Corporate Venture Funds Get Wrong about Strategic Value appeared first on MedCity News.
After the third day of squirting an experimental drug up his nose, Dylan Meetze felt horrible. “It was like I was underwater, like it took the most to do anything,” he said. Meetze stopped taking the drug but endured fatigue and anxiety for months afterward, and his eyes and muscles twitched, he said. He had…
The U.S. Senate candidates in Texas could hardly be more different: James Talarico, a former seminarian turned Democratic state lawmaker who speaks in calm cadences about love and empathy, and Ken Paxton, the pugnacious Republican state attorney general who speaks about a refusal to compromise. They share an enemy, though. They dislike social media’s effects…
When Carol Daniel, a veteran broadcast journalist who lives near St. Louis, was diagnosed with thyroid cancer in 2022, her husband encouraged her to seek a second opinion. She was worried that consulting another doctor might seem like a betrayal. Daniel said she wondered: “Am I cheating on him? Am I going behind his back?…